GI Flashcards
H2 blockers
Drugs: cimetidine, ranitidine, famotidine, nizatidine
MoA: REVERSIBLE block of histamine H2-receptors -> decreased H+ secretion by parietal cells
Use: Peptic ulcer, gastritis, mild esophageal reflux.
Toxicity:
Cimetidine: potent inhibitor of cytochrome P-450 (multiple drug interactions); it also has antiandrogenic effects (prolactin release, gynecomastia, impotence, decreased libido in males); can cross BBB (confusion, dizziness, headaches) & placenta
Cimetidine & ranitidine: decrease renal excretion of creatinine.
Other H2 blockers are relatively free of these effects.
PPIs
Drugs: omeprazole, lansoprazole, esomeprazole, pantoprazole, dexlansoprazole
MoA: IRREVERSIBLY inhibits H+/ K+ ATPase in stomach parietal cells.
Use: Peptic ulcer, gastritis, esophageal reflux, Zollinger-Ellison syndrome.
Toxicity: increased risk of C. diff infxn, pneumonia. Hip fractures, decreased serum Mg w/ long term use
Bismuth, sucralfate
MoA: bind to ulcer base, providing physical protection and allowing HCO3- secretion to reestablish pH gradient in the mucous layer.
Use: increases ulcer healing, treats traveler’s diarrhea.
Misoprostol
MoA: PGE1 analog. Increases production & secretion of gastric mucous barrier, decreases acid production.
Use: Prevention of NSAID-induced peptic ulcers; maintenance of a patent ductus arterioles. Also used to induce labor (ripens cervix).
Toxicity: Diarrhea. Contraindicated in women of childbearing potential (abortifacient).
Octreotide
MoA: long-acting somatostatin analog.
Use: acute variceal bleeds, acromegaly, VIPoma, and carcinoid tumors
Toxicity: nausea, cramps, steatorrhea
Antacid use
Can affect absorption, bioavailability, or urinary excretion of other drugs by altering gastric and urinary pH or by delaying gastric emptying.
All can cause hypokalemia.
Toxicity
Aluminum hydroxide: constipation and hypophosphatemia; proximal mm weakness, osteodystrophy, seizures. Mnemonic: aluMINIMUM amt of feces
Magnesium hydroxide: diarrhea, hyporeflexia, hypotension, cardiac arrest. Mnemonic: Mg= Must Go (to the bathroom)
Calcium carbonate: hypercalcemia, rebound acid hyper secretion. Can chelate and decrease effectiveness of other drugs (e.g. tetracycline)
Osmotic laxatives
Drugs: magnesium hydroxide, magnesium citrate, polyethylene glycol, lactulose
MoA: provide osmotic load to draw water out.
Lactulose also treats hepatic encephalopathy since gut flora degrade it into metabolites (lactic acid and acetic acid) that promote nitrogen excretion as NH4+
Use: constipation
Toxicity: diarrhea, dehydration; may be abused by bulimics
Infliximab
MoA: monoclonal antibody to TNF- alpha
Use: Crohn’s disease, ulcerative colitis, rheumatoid arthritis
Toxicity: infxn (including reactivation of latent TB), fever, hypotension
Sulfasalazine
MoA: a combination of sulfapyridine (antibacterial) and 5-aminosalicylic acid (anti-inflamm). Activated by colonic bacteria.
Use: ulcerative colitis, Crohn’s disease
Toxicity: malaise, nausea, sulfonamide toxicity, reversible oligospermia
Ondansetron
MoA: 5-HT3 antagonist. Powerful central-acting antiemetic.
Use: control vomiting postoperatively and in pts undergoing chemo
Toxicity: headache, constipation
Metoclopramide
MoA: D2 receptor antagonist. Increases resting tone, contractility, LES tone, motility. Does NOT influence colon transport time.
Clinical use: diabetic and post-surgery gastroparesis, antiemetic
Toxicity: Increased parkinsonian effects. Restlessness, drowsiness, fatigue, depression, nausea, diarrhea. Drug interaxn w digoxin and diabetic agents. Contraindicated in pts w/ small bowel obstruction or Parkinson’s disease